Articles from last issue

• The use of CRISPR/Cas9 gene editing system in the treatment of HBV infection, 1-7  

  http://dx.doi.org/10.29228/genediting.40389

  Medine Karadağ-Alpaslan

  • Abstract
  • Full text

• Gene editing studies for the treatment of AIDS, 8-20

  http://dx.doi.org/10.29228/genediting.40387

  Can Akpınaroğlu

  • Abstract
  • Full text

• Gene editing studies for the treatment of anemia, 21-29

  http://dx.doi.org/10.29228/genediting.40385

  Fatih Kocabas -Batuhan Mert Kalkan, Gulcin Delal Nozhatzadeh, Fatih Kocabas

  • Abstract
  • Full text

• Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobials, 30-35

  http://dx.doi.org/10.29228/genediting.41450

  CIHAN TASTAN -Aysegul Ates, Cihan Tastan, Safak Ermertcan

  • Abstract
  • Full text

• CRISPR-Cas9 based gene editing technologies in induced pluripotent stem cells, 36-41

  http://dx.doi.org/10.29228/genediting.40391

  Melek Yüce -Melek Yuce, Gulcin Delal Nozhatzadeh

  • Abstract
  • Full text